No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs545748203 |
chr6:163273722-163273723 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs73603881 |
chr6:163273735-163273736 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
3 |
rs532001772 |
chr6:163273761-163273762 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs531910597 |
chr6:163273827-163273828 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs568622803 |
chr6:163273854-163273855 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs185605648 |
chr6:163273885-163273886 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs79780861 |
chr6:163273890-163273891 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs570601445 |
chr6:163273897-163273898 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs76115844 |
chr6:163273912-163273913 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs568553553 |
chr6:163273981-163273982 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs536541310 |
chr6:163273984-163273985 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs556167834 |
chr6:163273985-163273986 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs116178493 |
chr6:163273986-163273987 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs535726492 |
chr6:163274025-163274026 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs112419082 |
chr6:163274049-163274050 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs12527753 |
chr6:163274054-163274055 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs78071473 |
chr6:163274111-163274112 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs540911365 |
chr6:163274124-163274125 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs117050298 |
chr6:163274126-163274127 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs146152878 |
chr6:163274208-163274209 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs529651163 |
chr6:163274249-163274250 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs373402847 |
chr6:163274285-163274286 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs190748474 |
chr6:163274288-163274289 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs12665063 |
chr6:163274306-163274307 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
mRNA abundance
|
25 |
rs183366523 |
chr6:163274337-163274338 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs140046356 |
chr6:163274339-163274340 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs189224914 |
chr6:163274340-163274341 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs34753567 |
chr6:163274390-163274391 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs60835899 |
chr6:163274393-163274394 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs141936244 |
chr6:163274411-163274412 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs193095479 |
chr6:163274412-163274413 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs564693032 |
chr6:163274421-163274422 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs34443744 |
chr6:163274428-163274429 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs183864216 |
chr6:163274529-163274530 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs55709292 |
chr6:163274540-163274541 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs12660616 |
chr6:163274561-163274562 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs535154379 |
chr6:163274602-163274603 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs139635101 |
chr6:163274621-163274622 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs570753270 |
chr6:163274673-163274674 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs142852527 |
chr6:163274688-163274689 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs538180480 |
chr6:163274715-163274716 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs557500208 |
chr6:163274744-163274745 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs112613716 |
chr6:163274752-163274753 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs13216389 |
chr6:163274757-163274758 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
45 |
rs559508735 |
chr6:163274774-163274775 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs557438082 |
chr6:163274778-163274779 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs186685348 |
chr6:163274818-163274819 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs35314719 |
chr6:163274868-163274869 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs576380101 |
chr6:163274899-163274900 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs541897715 |
chr6:163274970-163274971 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|